Acceptability of Cognitive Behavioral Therapy for Tinnitus: A Study With Veterans and Nonveterans.


Journal

American journal of audiology
ISSN: 1558-9137
Titre abrégé: Am J Audiol
Pays: United States
ID NLM: 9114917

Informations de publication

Date de publication:
06 Sep 2023
Historique:
pmc-release: 01 03 2024
medline: 7 9 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

Cognitive behavioral therapy (CBT) is a gold standard yet underutilized treatment for tinnitus, and tinnitus is especially highly prevalent among veterans. The aims of this study were twofold: to determine (a) if CBT for tinnitus is underutilized because participants find it less acceptable than other behavioral treatments for tinnitus and (b) if veterans and nonveterans rate behavioral treatments for tinnitus differently. This cross-sectional study was conducted online with a sample of 277 adults in the United States who self-reported at least some level of bothersome tinnitus in the past week. The sample for this study consisted of 129 veterans and 148 nonveterans. Participants read descriptions of CBT, tinnitus retraining therapy (TRT), and mindfulness-based stress reduction (MBSR). For each treatment, presented to them in random order, they provided credibility, expectancy, and acceptability ratings. Among 277 participants, 147 (53.07%) reporting gender were women, 216 (77.98%) reporting race/ethnicity were White, and 129 (46.57%) were veterans of any branch of the U.S. Armed Forces. Veteran ratings of credibility, expectancy, and acceptability were significantly lower than nonveteran ratings across treatments. There were differences in credibility, expectancy, and acceptability ratings across treatments, and post hoc testing revealed that TRT was consistently rated higher than CBT or MBSR. Despite strong research support, CBT was rated as less acceptable than a different, less widely empirically supported treatment. Veterans' ratings of acceptability were lower than those of nonveterans across all treatments.

Identifiants

pubmed: 37566882
doi: 10.1044/2023_AJA-23-00020
pmc: PMC10558150
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

593-603

Subventions

Organisme : NIDCD NIH HHS
ID : R01 DC017451
Pays : United States

Références

Am J Audiol. 2007 Dec;16(2):107-17
pubmed: 18056879
Int J Behav Med. 2018 Jun;25(3):312-321
pubmed: 29185182
Otolaryngol Head Neck Surg. 2014 Oct;151(2 Suppl):S1-S40
pubmed: 25273878
J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86
pubmed: 11132119
JAMA Otolaryngol Head Neck Surg. 2019 Jul 1;145(7):597-608
pubmed: 31120533
Depress Anxiety. 2018 Oct;35(10):953-965
pubmed: 30024639
J Am Acad Audiol. 2013 Sep;24(8):747-62
pubmed: 24131610
Lancet. 2013 Nov 9;382(9904):1600-7
pubmed: 23827090
BMC Psychiatry. 2006 Apr 07;6:14
pubmed: 16603060
JMIR Ment Health. 2022 May 11;9(5):e34655
pubmed: 35544305
J Health Commun. 2013;18 Suppl 1:273-89
pubmed: 24093361
Int Tinnitus J. 2011;16(2):118-22
pubmed: 22249870
J Am Acad Audiol. 2014 Jan;25(1):29-61
pubmed: 24622860
Front Neurosci. 2019 Aug 06;13:802
pubmed: 31447630
Front Neurol. 2019 Nov 01;10:1135
pubmed: 31736854
Ear Hear. 2012 Mar-Apr;33(2):153-76
pubmed: 22156949
Am J Med. 2010 Aug;123(8):711-8
pubmed: 20670725
Ear Hear. 2016 Sep-Oct;37(5):541-6
pubmed: 26950001
HNO. 2019 Mar;67(Suppl 1):10-42
pubmed: 30847513
Fed Pract. 2018 Aug;35(8):36-46
pubmed: 30766380
Am J Audiol. 2020 Sep 3;29(3):476-490
pubmed: 32880499
Psychol Bull. 1990 Mar;107(2):238-46
pubmed: 2320703
Clin Psychol Rev. 2011 Jun;31(4):545-53
pubmed: 21237544
ORL J Otorhinolaryngol Relat Spec. 2006;68(1):23-9; discussion 29-30
pubmed: 16514259
N Engl J Med. 2002 Sep 19;347(12):904-10
pubmed: 12239260
J Am Acad Audiol. 2018 Apr;29(4):313-336
pubmed: 29664725
Am J Audiol. 2021 Jun 14;30(2):404-415
pubmed: 34029120
J Gen Intern Med. 2016 Oct;31(10):1206-11
pubmed: 27170304
Am J Audiol. 2019 Apr 22;28(1S):181-190
pubmed: 31022360
US Army Med Dep J. 2016 Oct-Dec;(3-16):52-63
pubmed: 27613210
J Head Trauma Rehabil. 2014 Sep-Oct;29(5):432-42
pubmed: 23982788
JAMA Otolaryngol Head Neck Surg. 2016 Oct 1;142(10):959-965
pubmed: 27441392
Laryngoscope Investig Otolaryngol. 2017 May 28;2(4):166-177
pubmed: 28894836
J Laryngol Otol. 2008 Oct;122(10):1052-6
pubmed: 18353195
BMC Health Serv Res. 2017 Jan 26;17(1):88
pubmed: 28126032
Laryngoscope. 2017 Feb;127(2):466-469
pubmed: 27301552
J Psychosom Res. 2010 Sep;69(3):289-98
pubmed: 20708451
Otolaryngol Head Neck Surg. 2015 May;152(5):919-26
pubmed: 25715350
J Rehabil Res Dev. 2014;51(4):609-22
pubmed: 25144174
Prog Brain Res. 2021;260:1-25
pubmed: 33637213
Int J Audiol. 2010 Aug;49(8):574-9
pubmed: 20500032
J Am Acad Audiol. 2000 Mar;11(3):162-77
pubmed: 10755812
N Engl J Med. 2018 Mar 29;378(13):1224-1231
pubmed: 29601255
Med Humanit. 2019 Dec;45(4):408-415
pubmed: 31740577

Auteurs

Chavez R Rodriguez (CR)

Department of Psychiatry, University of Michigan, Ann Arbor.
Addiction Center, University of Michigan, Ann Arbor.

Jay F Piccirillo (JF)

Clinical Outcomes Research Office, Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine in St. Louis, MO.

Thomas L Rodebaugh (TL)

Department of Psychological & Brain Sciences, Washington University in St. Louis, MO.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH